Artis BioSolutions

Landmark BioBiotechUnited States

73% match

Landmark Bio is an Artis BioSolutions biotechnology research company headquartered in Watertown, Massachusetts. It is dedicated to accelerating the translation and development of next-generation advanced genetic medicines.

Cirsium BiosciencesLife SciencesUnited States

71% match

Cirsium Biosciences is a San Diego-based biotech company focused on democratizing gene therapy. The company is redefining AAV production through transformative viral vector production methods and systems.

AGC BiologicsBiotechUnited States

66% match

AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.

Flash Therapeutics is a French biotechnology company specializing in lentiviral vector technologies and gene-delivery solutions. It serves academic and pharmaceutical/biotechnology researchers, including through development and GMP manufacturing services for gene-therapy applications.

ElevateBio is a biotechnology company that builds and operates cell and gene therapy companies and provides development, manufacturing, and technology capabilities through its platform, including BaseCamp. It serves biotech and pharmaceutical organizations developing advanced therapies, as well as supporting the creation of new therapeutic companies.

GenScript1548.HK · BiotechChina

64% matchPublicAI 33/100 ▲Green 5/100 ▼

Operating as an investment holding company, Genscript Biotech Corporation, established in 2002 and headquartered in Nanjing, People's Republic of China, specializes in the global provision of innovative life science research solutions, encompassing both products and services. Its market presence spans North America, Europe, China, Japan, other Asia Pacific regions, and numerous international markets. The enterprise structures its operations into four key divisions: The Life Science Services and Products segment delivers a wide array of research offerings, such as gene and oligonucleotide synthesis, molecular cloning, protein and peptide engineering, antibody production, molecular diagnostic instruments, and genomic editing materials. These resources are instrumental for fundamental biological investigations, pharmaceutical and drug discovery, disease diagnostics, vaccine development, and applications in agriculture, environmental science, and food production. The Biologics Development Services division supports pharmaceutical, biotechnology, governmental, and academic institutions. It provides comprehensive services for the full lifecycle of therapeutic antibodies, from initial discovery through pre-clinical and clinical development, alongside pre-clinical and clinical development for plasmids and viruses, and broader gene and cell therapy development. Dedicated to industrial applications, the Industrial Synthetic Biology Products segment engineers non-pathogenic microbial strains and manufactures specialized enzymes. These enzymes find utility across the food processing, animal feed, pharmaceutical, and chemical sectors. Finally, the Cell Therapy unit focuses on the pioneering discovery and advanced development of chimeric antigen receptor T-cell (CAR-T) therapies, specifically designed to combat both liquid and solid malignant tumors.